Antidepressant treatment and emotional processing: Can we dissociate the roles of serotonin and noradrenaline?

Journal of Psychopharmacology

Volumn 27, Issue 8, 2013, Pages 719-731

  Pringle, A ^a   McCabe, C ^a   Cowen, P J ^a   Harmer, C J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

antidepressants; Depression; emotional blunting; emotional memory; emotional processing; noradrenaline; reward; serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; NORADRENALIN; REBOXETINE; SEROTONIN;

ANHEDONIA; ARTICLE; BOLD SIGNAL; DEPRESSION; DISTRESS SYNDROME; DRUG EFFECT; DRUG MECHANISM; EMOTION; EMOTIONAL MEMORY; FACIAL EXPRESSION; HUMAN; MEMORY; MEMORY DISORDER; MENTAL PERFORMANCE; MENTAL TASK; MOOD CHANGE; NERVE CELL NETWORK; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECOGNITION; REWARD; SEROTONIN RELEASE; SEROTONINERGIC TRANSMISSION; SINGLE DRUG DOSE; TASK PERFORMANCE;

ANTIDEPRESSANTS; DEPRESSION; EMOTIONAL BLUNTING; EMOTIONAL MEMORY; EMOTIONAL PROCESSING; NORADRENALINE; REWARD; SEROTONIN;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; HUMANS; NOREPINEPHRINE; SEROTONIN;

EID: 84880493661     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112474523     Document Type: Article

References (146)

1. Abler B, Grön G, Hartmann A, et al. Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs. J Neurosci. 2012 ; 32: 1329-1335
2. Abler B, Seeringer A, Hartmann A, et al. Neural correlates of antidepressant-related sexual dysfunction: A placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion. Neuropsychopharmacology. 2011 ; 36: 1837-1847
3. Allen NB, Trinder J, Brennan C. Affective startle modulation in clinical depression: Preliminary findings. Biol Psychiatry. 1999 ; 46: 542-550
4. Arnone D, Horder J, Cowen PJ, et al. Early effects of mirtazapine on emotional processing. Psychopharmacology. 2009 ; 203: 685-691
5. Arnsten AF. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci. 1998 ; 2: 436-447
6. Aston-Jones G, Rajkowski J, Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry. 1999 ; 46: 1309-1320
7. Beck AT, Rush AJ, Shaw BF, et al Cognitive Therapy of Depression. New York: Guildford Press ; 1979:
8. Berenbaum H, Oltmanns TF. Emotional experience and expression in schizophrenia and depression. J Abnorm Psychol. 1992 ; 101: 37-44
9. Berridge C. Noradrenergic modulation of arousal. Brain Res Rev. 2008 ; 58: 1-17
10. Bjork J, Hommer D. Anticipating instrumentally obtained and passively-received rewards: A factorial fMRI investigation. Behav Brain Res. 2007 ; 177: 165-170
11. Bouhuys AL, Geerts E, Gordijn MC. Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: A longitudinal study. J Nerv Ment Dis. 1999 ; 187: 595-602
12. Bower GH. Mood and memory. Am Psychol. 1981 ; 36: 129-148
13. Bradley BP, Mogg K, Millar N. Implicit memory bias in clinical and non-clinical depression. Behav Res Ther. 1996 ; 34: 865-879
14. BradleyAJLenox-SmithAJ (in press) Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A review of meta-analyses and large randomised pragmatic trials. J Psychopharmacology.
15. Bradley BP, Mogg K, Williams R. Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety. Behav Res Ther. 1995 ; 33: 755-770
16. Browning M, Grol M, Ly V, et al. Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety. Neuropsychopharmacology. 2011 ; 36: 2689-2697
17. Browning M, Reid C, Cowen PJ, et al. A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol. 2007 ; 21: 684-690
18. Brozoski TJ, Brown RM, Rosvold HE, et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 1979 ; 205: 929-932
19. Brühl AB, Jäncke L, Herwig U. Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants. Psychopharmacology. 2011 ; 216: 389-399
20. Brühl AB, Kaffenberger T, Herwig U. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology. 2010 ; 35: 521-533
21. Cahill L, McGaugh JL. Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci. 1998 ; 21: 294-299
22. Cahill L, Prins B, Weber M, et al. Beta-adrenergic activation and memory for emotional events. Nature. 1994 ; 371: 702-704
23. Chandra P, Hafizi S, Massey-Chase RM, et al. NK1 receptor antagonism and emotional processing in healthy volunteers. J Psychopharmacol. 2010 ; 24: 481-487
24. Crockett MJ, Clark L, Roiser JP, et al. Converging evidence for central 5-HT effects in acute tryptophan depletion. Mol Psychiatry. 2012 ; 17: 121-123
25. Deakin JW, Williams S, Downey D, et al. PharmacoMRI and cognitive effects of the low-trapping NMDA channel blocker AZD6765 compared with ketamine in untreated major depressive disorder. 28th CINP World Congress of Neuropsychopharmacology ; 2012 Stockholm, Sweden ; 2012..
26. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012 ; 35: 68-77
27. Dhillon S, Scott L, Plosker G. Escitalopram: A review of its use in the management of anxiety disorders. CNS Drugs. 2006 ; 20: 763-790
28. Dichter G, Tomarken A, Shelton R, et al. Early- and late-onset startle modulation in unipolar depression. Psychophysiology. 2004 ; 41: 433-440
29. Dolcos F, LaBar K, Cabeza R. Remembering one year later: Role of the amygdala and the medial temporal lobe memory system in retrieving emotional memories. Proc Natl Acad Sci U S A. 2005 ; 102: 2626-2631
30. Drevets WC, Furey ML. Replication of scopolamine's antidepressant efficacy in major depressive disorder: A randomized, placebo-controlled clinical trial. Biol Psychiatry. 2010 ; 67: 432-438
31. Ekman P. Facial expression and emotion. Am Psychol. 1993 ; 48: 384-392
32. Elliott R, Sahakian BJ, Michael A, et al. Abnormal neural response to feedback on planning and guessing tasks in patients with unipolar depression. Psychol Med. 1998 ; 28: 559-571
33. Elliott R, Zahn R, Deakin W, et al. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology. 2011 ; 36: 153-182
34. Eyding D, Lelgemann M, Grouven U, et al. Reboxetine for acute treatment of major depression: Systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ. 2010 ; 341: c4737
35. Fava M. Pharmacological approaches to the treatment of residual symptoms. J Psychopharmacol. 2006 ; 20: 29-34
36. Forbes E, Miller A, Cohn J, et al. Affect-modulated startle in adults with childhood-onset depression: Relations to bipolar course and number of lifetime depressive episodes. Psychiatry Res. 2005 ; 134: 11-25
37. Fossati P, Hevenor S, Graham S, et al. In search of the emotional self: An fMRI study using positive and negative emotional words. Am J Psychiatry. 2003 ; 160: 1938-1945
38. Fu C, Williams S, Brammer M, et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry. 2007 ; 164: 599-607
39. Fu C, Williams S, Cleare A, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry. 2004 ; 61: 877-889
40. Fuster JM. Executive frontal functions. Exp Brain Res. 2000 ; 133: 66-70
41. Fuxe K, Hamberger B, Hökfelt T. Distribution of noradrenaline nerve terminals in cortical areas of the rat. Brain Res. 1968 ; 8: 125-131
42. Gilboa-Schechtman E, Erhard-Weiss D, Jeczemien P. Interpersonal deficits meet cognitive biases: Memory for facial expressions in depressed and anxious men and women. Psychiatry Res. 2002 ; 113: 279-293
43. Glowinski J, Axelrod J. Inhibition of uptake of tritiated- noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature. 1964 ; 204: 1318-1319
44. Grillon C, Levenson J, Pine D. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: A fear-potentiated startle study. Neuropsychopharmacology. 2007 ; 32: 225-231
45. Gur RC, Erwin RJ, Gur RE, et al. Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res. 1992 ; 42: 241-251
46. Harmer C, Bhagwagar Z, Cowen P, et al. Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacology. 2002 ; 163: 106-110
47. Harmer C, Cowen P, Goodwin G. Efficacy markers in depression. J Psychopharmacol. 2011a ; 25: 1148-1158
48. Harmer C, de Bodinat C, Dawson G, et al. Agomelatine facilitates positive versus negative affective processing in healthy volunteer models. J Psychopharmacol. 2011b ; 25: 1159-1167
49. Harmer C, Goodwin G, Cowen P. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009a ; 195: 102-108
50. Harmer C, Hill S, Taylor M, et al. Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry. 2003a ; 160: 990-992
51. Harmer C, Mackay C, Reid C, et al. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry. 2006a ; 59: 816-820
52. Harmer C, O'Sullivan U, Favaron E, et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009b ; 166: 1178-1184
53. Harmer C, Shelley N, Cowen P, et al. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry. 2004 ; 161: 1256-1263
54. Harmer CJ. Serotonin and emotional processing: Does it help explain antidepressant drug action?. Neuropharmacology. 2008 ; 55: 1023-1028
55. Harmer CJ, Bhagwagar Z, Perrett DI, et al. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology. 2003b ; 28: 148-152
56. Harmer CJ, Heinzen J, O'Sullivan U, et al. Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. Psychopharmacology. 2008 ; 199: 495-502
57. Harmer CJ, Reid CB, Ray MK, Goodwin GM, Cowen PJ. 5HT(3) antagonism abolishes the emotion potentiated startle effect in humans. Psychopharmacology. 2006b ; 186: 18-24
58. Hasler G, Drevets W, Manji H, et al. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004 ; 29: 1765-1781
59. Heine SJ, Lehman DR, Markus HR, et al. Is there a universal need for positive self-regard?. Psychological Rev. 1999 ; 106: 766-794
60. Horder J, Browning M, Di Simplicio M, et al. Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. J Psychopharmacol. 2012 ; 26: 125-132
61. Horder J, Cowen P, Di Simplicio M, et al. Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology. 2009 ; 205: 85-91
62. Hurlemann R. Noradrenergic control of emotion-induced amnesia and hypermnesia. Rev Neurosci. 2006 ; 17: 525-532
63. Keedwell P, Andrew C, Williams S, et al. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry. 2005 ; 58: 843-853
64. Keller M, Montgomery S, Ball W, et al. Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry. 2006 ; 59: 216-223
65. Kent JM, Coplan JD, Gorman JM. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry. 1998 ; 44: 812-824
66. Kessler R, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 ; 62: 617-627
67. Knutson B, Bhanji J, Cooney R, et al. Neural responses to monetary incentives in major depression. Biol Psychiatry. 2008 ; 63: 686-692
68. Kringelbach M, Rolls E. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol. 2004 ; 72: 341-372
69. Kuhn R. [Treatment of depressive states with an iminodibenzyl derivative (G 22355)]. Schweiz Med Wochenschr. 1957 ; 87: 1135-1140
70. Kukolja J, Klingmüller D, Maier W, et al. Noradrenergic- glucocorticoid modulation of emotional memory encoding in the human hippocampus. Psychol Med. 2011 ; 41: 2167-2176
71. Kumar P, Waiter G, Ahearn T, et al. Abnormal temporal difference reward-learning signals in major depression. Brain. 2008 ; 131: 2084-2093
72. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000 ; 23: 155-184
73. Leppänen J. Emotional information processing in mood disorders: A review of behavioral and neuroimaging findings. Curr Opin Psychiatry. 2006 ; 19: 34-39
74. Loomer HP, Saunders JC, Kline NS. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep. 1957 ; 8: 129-141
75. MacLeod C, Mathews A, Tata P. Attentional bias in emotional disorders. J Abnorm Psychol. 1986 ; 95: 15-20
76. MacLeod C, Rutherford E, Campbell L, et al. Selective attention and emotional vulnerability: Assessing the causal basis of their association through the experimental manipulation of attentional bias. J Abnorm Psychol. 2002 ; 111: 107-123
77. Maheu F, Joober R, Beaulieu S, et al. Differential effects of adrenergic and corticosteroid hormonal systems on human short- and long-term declarative memory for emotionally arousing material. Behav Neurosci. 2004 ; 118: 420-428
78. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol. 2005 ; 1: 167-195
79. Mayberg H. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003 ; 65: 193-207
80. McCabe C, Cowen P, Harmer C. Neural representation of reward in recovered depressed patients. Psychopharmacology. 2009 ; 205: 667-677
81. McCabe C, Mishor Z, Cowen P, et al. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry. 2010 ; 67: 439-445
82. McGaugh J. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci. 2004 ; 27: 1-28
83. McGrath PJ, Khan AY, Trivedi MH, et al. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: A STAR *D report. J Clin Psychiatry. 2008 ; 69: 1847-1855
84. Millan MJ, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 2003 ; 306: 954-964
85. Miskowiak K, Papadatou-Pastou M, Cowen P, et al. Single dose antidepressant administration modulates the neural processing of self-referent personality trait words. NeuroImage. 2007 ; 37: 904-911
86. Mogg K, Bradley BP. A cognitive-motivational analysis of anxiety. Behav Res Ther. 1998 ; 36: 809-848
87. Mogg K, Bradley BP, Williams R. Attentional bias in anxiety and depression: the role of awareness. Br J Clin Psychol. 1995 ; 34: 17-36
88. Murphy S. Using functional neuroimaging to investigate the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs). Curr Pharm Des. 2010 ; 16: 1990-1997
89. Murphy S, Yiend J, Lester K, et al. Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. Int J Neuropsychopharmacol. 2009 ; 12: 169-179
90. Murphy SE, Downham C, Cowen PJ, et al. Direct effects of diazepam on emotional processing in healthy volunteers. Psychopharmacology. 2008 ; 199: 503-513
91. Murrough JW, Perez AM, Pillemer S, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2012 ;:
92. Nelson C, Portera L, Leon A. Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?. Biol Psychiatry. 2005 ; 57: 1535-1542
93. Nelson JC, Charney DS. The symptoms of major depressive illness. Am J Psychiatry. 1981 ; 138: 1-13
94. Nestler E, Hyman S. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010 ; 13: 1161-1169
95. CG22 Anxiety: NICE Guideline (amended). London: National Institute for Clinical Excellence ; 2007:
96. Norbury R, Mackay C, Cowen P, et al. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br J Psychiatry. 2007 ; 190: 531-532
97. Norbury R, Mackay CE, Cowen PJ, et al. The effects of reboxetine on emotional processing in healthy volunteers: An fMRI study. Mol Psychiatry. 2008 ; 13: 1011-1020
98. Norbury R, Taylor M, Selvaraj S, et al. Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology. 2009 ; 206: 197-204
99. Northoff G, Heinzel A, de Greck M, et al. Self-referential processing in our brain - a meta-analysis of imaging studies on the self. NeuroImage. 2006 ; 31: 440-457
100. Nutt D, Demyttenaere K, Janka Z, et al. The other face of depression, reduced positive affect: The role of catecholamines in causation and cure. J Psychopharmacol. 2007 ; 21: 461-471
101. O'Carroll RE, Drysdale E, Cahill L, et al. Memory for emotional material: A comparison of central versus peripheral beta blockade. J Psychopharmacol. 1999a ; 13: 32-39
102. O'Carroll RE, Drysdale E, Cahill L, et al. Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man. Psychol Med. 1999b ; 29: 1083-1088
103. Onur O, Walter H, Schlaepfer T, et al. Noradrenergic enhancement of amygdala responses to fear. Soc Cogn Affect Neurosci. 2009 ; 4: 119-126
104. Ossewaarde L, Verkes R, Hermans E, et al. Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits. Biol Psychiatry. 2011 ; 70: 568-574
105. Papakostas GI, Nelson JC, Kasper S, et al. A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Neuropsychopharmacol. 2008 ; 18 (2). 122-127
106. Papps B, Shajahan P, Ebmeier K, et al. The effects of noradrenergic re-uptake inhibition on memory encoding in man. Psychopharmacology. 2002 ; 159: 311-318
107. Park SB, Coull JT, McShane RH, et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology. 1994 ; 33: 575-588
108. Parnavelas JG, Papadopoulos GC. The monoaminergic innervation of the cerebral cortex is not diffuse and nonspecific. Trends Neurosci. 1989 ; 12: 315-319
109. Price J, Cole V, Goodwin G. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry. 2009 ; 195: 211-217
110. Pringle A, Browning M, Cowen PJ, et al. A cognitive neuropsychological model of antidepressant drug action. Prog Neuropsychopharmacol Biol Psychiatry. 2011 ; 35: 1586-1592
111. Pringle A, Parsons L, Cowen L, et al. Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine. J Psychopharmacol. 2012 ; 26: 1417-1423
112. Rawlings N, Norbury R, Cowen P, et al. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology. 2010 ; 212: 625-634
113. Reist C, Duffy JG, Fujimoto K, et al. beta-Adrenergic blockade and emotional memory in PTSD. Int J Neuropsychopharmacol. 2001 ; 4: 377-383
114. Richardson M, Strange B, Dolan R. Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nat Neurosci. 2004 ; 7: 278-285
115. Ridout N, Astell A, Reid I, et al. Memory bias for emotional facial expressions in major depression. Cogn Emot. 2003 ;: 101-122
116. Riedel WJ, Klaassen T, Deutz NE, et al. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology. 1999 ; 141: 362-369
117. Robinson E. Rodent models of emotional dysfunction: Potential targets for treatment. British Association for Psychopharmacology Summer Meeting ; 2012 Harrogate, UK ; 2012..
118. Roiser J, Elliott R, Sahakian B. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology. 2012 ; 37: 117-136
119. Roiser JP, Levy J, Fromm SJ, et al. The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology. 2008 ; 33: 1992-2006
120. Ross SB, Renyi AL. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur J Pharmacol. 1969 ; 7: 270-277
121. Rush J, Trivedi M, Wisniewski S, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR *D report. Am J Psychiatry. 2006 ; 163: 1905-1917
122. Satel SL, Nelson JC. Stimulants in the treatment of depression: A critical overview. J Clin Psychiatry. 1989 ; 50: 241-249
123. Schaefer H, Putnam K, Benca R, et al. Event-related functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre- and post-treatment depression. Biol Psychiatry. 2006 ; 60: 974-986
124. Schmitt JA, Jorissen BL, Sobczak S, et al. Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J Psychopharmacol. 2000 ; 14: 21-29
125. Seedat S, van Rheede van Oudtshoorn E, Muller J, et al. Reboxetine and citalopram in panic disorder: A single-blind, cross-over, flexible-dose pilot study. Int Clin Psychopharmacol. 2003 ; 18: 279-284
126. Sheline YI, Barch DM, Donnelly JM, et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry. 2001 ; 50: 651-658
127. Shelton RC, Tomarken AJ. Can recovery from depression be achieved?. Psychiatr Serv. 2001 ; 52: 1469-1478
128. Simon G, Perlis R. Personalized medicine for depression: Ccan we match patients with treatments?. Am J Psychiatry. 2010 ; 167: 1445-1455
129. Steele JD, Kumar P, Ebmeier KP. Blunted response to feedback information in depressive illness. Brain. 2007 ; 130: 2367-2374
130. Strange BA, Dolan RJ. Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci U S A. 2004 ; 101: 11454-11458
131. Surguladze S, Brammer M, Keedwell P, et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry. 2005 ; 57: 201-209
132. Tendolkar I, van Wingen G, Urner M, et al. Short-term duloxetine administration affects neural correlates of mood-congruent memory. Neuropsychopharmacology. 2011 ; 36: 2266-2275
133. Tranter R, Bell D, Gutting P, et al. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord. 2009 ; 118: 87-93
134. Trivedi M, Rush J, Wisniewski S, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR *D: Implications for clinical practice. Am J Psychiatry. 2006 ; 163: 28-40
135. Uher R, Maier W, Hauser J, et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry. 2009 ; 194: 252-259
136. van Marle H, Tendolkar I, Urner M, et al. Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals. NeuroImage. 2011 ; 55: 825-831
137. van Stegeren A. The role of the noradrenergic system in emotional memory. Acta Psychol. 2008 ; 127: 532-541
138. van Stegeren A, Goekoop R, Everaerd W, et al. Noradrenaline mediates amygdala activation in men and women during encoding of emotional material. NeuroImage. 2005 ; 24: 898-909
139. van Stegeren AH, Everaerd W, Cahill L, et al. Memory for emotional events: Differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology. 1998 ; 138: 305-310
140. Versiani M, Cassano G, Perugi G, et al. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry. 2002 ; 63: 31-37
141. Vogt B. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci. 2005 ; 6: 533-544
142. Vuilleumier P. How brains beware: neural mechanisms of emotional attention. Trends Cogn Sci. 2005 ; 9: 585-594
143. Watson D, Tellegen A. Toward a consensual structure of mood. Psychol Bull. 1985 ; 98: 219-235
144. Windischberger C, Lanzenberger R, Holik A, et al. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study. NeuroImage. 2010 ; 49: 1161-1170
145. Zahrt J, Taylor JR, Mathew RG, et al. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci. 1997 ; 17: 8528-8535
146. Zarate C, Singh J, Quiroz J, et al. A double-blind, placebo- controlled study of memantine in the treatment of major depression. Am J Psychiatry. 2006 ; 163: 153-155